28 July 2016EuropeStephanie Pilkington and Ling Zhuang
EPO opposition reforms: the changing face of central patent revocation
Changes in July to opposition practice at the European Patent Office (EPO), as well as the decision of the Administrative Council (AC) of the EPO to reform the boards of appeal, reflect a common theme—the need for greater efficiency at the EPO. These reforms have occurred at a time of speculation about how the possible co-existence of the Unified Patent Court (UPC) alongside the established EPO opposition procedure will affect decision-making surrounding attacks on the validity of European patents.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
28 May 2026 A European court dismissed a challenge by a German generics manufacturer, confirming the validity of a patent covering a blood cancer combination therapy.
21 May 2026 The court has imposed a financial penalty after finding it continued promoting banned devices online despite an injunction covering five European countries.
18 May 2026 A high-profile Paris-based partner and four others join the firm, bringing experience across M&A, venture capital and life sciences-focused transactions.